DRIMANIC SESQUITERPENES AND LICHENS METABOLITES AS A BUILDING BLOCK FOR THE SYNTHESIS OF NEW SESQUTERPEN-ORCINOL DERIVATIVES, AS POTENTIAL TOPOISOMERASE I/II AND/OR PDK1 KINASE INHIBITORS